You are here

  • Home
  • Archive
  • Volume 78, Issue 5
  • Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD

Article info

Article menu
Download PDFPDF
Chronic obstructive pulmonary disease
Original research
Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD

Authors

  • Susan Muiser Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Kai Imkamp Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Dianne Seigers Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Nynke J Halbersma Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Judith M Vonk Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands Department of Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Bart H D Luijk Department of Pulmonology, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Gert-Jan Braunstahl Department of Pulmonology, Franciscus Gasthuis, Rotterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Jan-Willem van den Berg Department of Pulmonology, Isala Hospital, Zwolle, The Netherlands PubMed articlesGoogle scholar articles
  • Bart-Jan Kroesen Laboratory of Medical Immunology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Janwillem W H Kocks Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands General Practitioners Research Institute, Groningen, The Netherlands Observational and Pragmatic Research Institute Pte Ltd, Singapore PubMed articlesGoogle scholar articles
  • Irene H Heijink Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Helen K Reddel Woolcock Institute of Medical Research, Glebe, New South Wales, Australia The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Huib A M Kerstjens Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Maarten van den Berge Department of Pulmonology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Susan Muiser, Department of Pulmonology, University Medical Centre Groningen, Groningen 9713, The Netherlands; s.muiser{at}umcg.nl
View Full Text

Citation

Muiser S, Imkamp K, Seigers D, et al
Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD
Thorax 2023;78:451-458.

Publication history

  • Received October 7, 2022
  • Accepted December 19, 2022
  • First published February 1, 2023.
Online issue publication 
October 24, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.